WEKO3
アイテム
{"_buckets": {"deposit": "285b22b2-c92c-4f2a-9b13-ffb5efcf99bc"}, "_deposit": {"created_by": 1, "id": "47076", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "47076"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00047076", "sets": ["1"]}, "author_link": ["470150", "470163", "470165", "470158", "470171", "470168", "470155", "470169", "470148", "470162", "470167", "470154", "470172", "470149", "470170", "470157", "470159", "470147", "470166", "470164", "470153", "470151", "470152", "470161", "470156", "470160"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2015-04", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "4", "bibliographicPageEnd": "412", "bibliographicPageStart": "406", "bibliographicVolumeNumber": "42", "bibliographic_titles": [{"bibliographic_title": "Nuclear Medicine and Biology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Introduction: The functions of I2-imidazoline receptors (I2Rs) are unknown, but evidence\nexists for their involvement in various neuropsychiatric disorders. Although a few positron emission\ntomography (PET) I2R ligands have been developed, of which [11C]FTIMD and [11C]BU99008 were\nevaluated as PET I2R imaging ligands in monkeys, no human PET imaging study using an I2R-selective\nPET ligand has been conducted yet. Thus, we synthesized an 18F-labeled I2R-selective ligand\n(BU99018 or FEBU, Ki for I2Rs = 2.6 nM), and evaluated its application using rodents in PET imaging in\nvivo toward the development of a clinically-useful I2R PET imaging ligand.\nMethods: [18F]FEBU was synthesized by the reaction of its precursor and [18F]fluoroethyl bromide. A\nbiodistribution and brain PET study were conducted in mice and rats, respectively.\nResults: [18F]FEBU was successfully synthesized, yielding a radioactivity suitable for injection (10.1 ±\n5.3% at the end of the irradiation (n = 10) based on 18F-). The specific activity at end of synthesis\n(EOS) was 40-147 TBq/mmol (n = 10). The radiochemical purity was \u003e99% at EOS and remained\n\u003e99% for 90 min after EOS. In mice, brain uptake was relatively high. In the blocking study with the coinjection\nof the high-affinity I2R ligand BU224 (1 mg/kg b.w.), brain uptake was significantly decreased\n30 min post-injection. In the PET studies, the radioactivity was highly accumulated in the I2R-rich\nhypothalamus. Pretreatment with BU224 (1 mg/kg b.w.) significantly decreased the radioactivity in\nthe hypothalamus to 23% of that of the control from 60 to 90 min post-injection.\nConclusion: [18F]FEBU was sufficiently stable as a PET ligand and had a relatively high specific binding\naffinity for I2Rs in rats and mice.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Elsevier"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kawamura, Kazunori"}], "nameIdentifiers": [{"nameIdentifier": "470147", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimoda, Yoko"}], "nameIdentifiers": [{"nameIdentifier": "470148", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kumata, Katsushi"}], "nameIdentifiers": [{"nameIdentifier": "470149", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujinaga, Masayuki"}], "nameIdentifiers": [{"nameIdentifier": "470150", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yui, Joji"}], "nameIdentifiers": [{"nameIdentifier": "470151", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamasaki, Tomoteru"}], "nameIdentifiers": [{"nameIdentifier": "470152", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Xie, Lin"}], "nameIdentifiers": [{"nameIdentifier": "470153", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hatori, Akiko"}], "nameIdentifiers": [{"nameIdentifier": "470154", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Wakizaka, Hidekatsu"}], "nameIdentifiers": [{"nameIdentifier": "470155", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yusuke, Kurihara"}], "nameIdentifiers": [{"nameIdentifier": "470156", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ogawa, Masanao"}], "nameIdentifiers": [{"nameIdentifier": "470157", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nengaki, Nobuki"}], "nameIdentifiers": [{"nameIdentifier": "470158", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong"}], "nameIdentifiers": [{"nameIdentifier": "470159", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "河村 和紀", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470160", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "下田 陽子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470161", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "熊田 勝志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470162", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "藤永 雅之", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470163", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "由井 譲二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470164", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山崎 友照", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470165", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "謝 琳", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470166", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "羽鳥 晶子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470167", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "脇坂 秀克", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470168", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "栗原 雄祐", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470169", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小川 政直", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470170", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "念垣 信樹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470171", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "張 明栄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "470172", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "In vivo evaluation of a new 18F-labeled PET ligand, [18F]FEBU, for the imaging of I2-imidazoline receptors", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "In vivo evaluation of a new 18F-labeled PET ligand, [18F]FEBU, for the imaging of I2-imidazoline receptors"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/47076", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-04-07"}, "publish_date": "2015-04-07", "publish_status": "0", "recid": "47076", "relation": {}, "relation_version_is_last": true, "title": ["In vivo evaluation of a new 18F-labeled PET ligand, [18F]FEBU, for the imaging of I2-imidazoline receptors"], "weko_shared_id": -1}
In vivo evaluation of a new 18F-labeled PET ligand, [18F]FEBU, for the imaging of I2-imidazoline receptors
https://repo.qst.go.jp/records/47076
https://repo.qst.go.jp/records/47076947d164b-5795-4efd-9666-b7fbe5f7b725
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-04-07 | |||||
タイトル | ||||||
タイトル | In vivo evaluation of a new 18F-labeled PET ligand, [18F]FEBU, for the imaging of I2-imidazoline receptors | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kawamura, Kazunori
× Kawamura, Kazunori× Shimoda, Yoko× Kumata, Katsushi× Fujinaga, Masayuki× Yui, Joji× Yamasaki, Tomoteru× Xie, Lin× Hatori, Akiko× Wakizaka, Hidekatsu× Yusuke, Kurihara× Ogawa, Masanao× Nengaki, Nobuki× Zhang, Ming-Rong× 河村 和紀× 下田 陽子× 熊田 勝志× 藤永 雅之× 由井 譲二× 山崎 友照× 謝 琳× 羽鳥 晶子× 脇坂 秀克× 栗原 雄祐× 小川 政直× 念垣 信樹× 張 明栄 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Introduction: The functions of I2-imidazoline receptors (I2Rs) are unknown, but evidence exists for their involvement in various neuropsychiatric disorders. Although a few positron emission tomography (PET) I2R ligands have been developed, of which [11C]FTIMD and [11C]BU99008 were evaluated as PET I2R imaging ligands in monkeys, no human PET imaging study using an I2R-selective PET ligand has been conducted yet. Thus, we synthesized an 18F-labeled I2R-selective ligand (BU99018 or FEBU, Ki for I2Rs = 2.6 nM), and evaluated its application using rodents in PET imaging in vivo toward the development of a clinically-useful I2R PET imaging ligand. Methods: [18F]FEBU was synthesized by the reaction of its precursor and [18F]fluoroethyl bromide. A biodistribution and brain PET study were conducted in mice and rats, respectively. Results: [18F]FEBU was successfully synthesized, yielding a radioactivity suitable for injection (10.1 ± 5.3% at the end of the irradiation (n = 10) based on 18F-). The specific activity at end of synthesis (EOS) was 40-147 TBq/mmol (n = 10). The radiochemical purity was >99% at EOS and remained >99% for 90 min after EOS. In mice, brain uptake was relatively high. In the blocking study with the coinjection of the high-affinity I2R ligand BU224 (1 mg/kg b.w.), brain uptake was significantly decreased 30 min post-injection. In the PET studies, the radioactivity was highly accumulated in the I2R-rich hypothalamus. Pretreatment with BU224 (1 mg/kg b.w.) significantly decreased the radioactivity in the hypothalamus to 23% of that of the control from 60 to 90 min post-injection. Conclusion: [18F]FEBU was sufficiently stable as a PET ligand and had a relatively high specific binding affinity for I2Rs in rats and mice. |
|||||
書誌情報 |
Nuclear Medicine and Biology 巻 42, 号 4, p. 406-412, 発行日 2015-04 |
|||||
出版者 | ||||||
出版者 | Elsevier |